Corporate Policy #307, Solid Waste Recycling

 

Directs all operating units to establish a goal of minimizing the quantity of solid waste generated by the Company.  Options which must be considered are recycling, reclamation and reuse where economically and environmentally practicable.  The Company authorizes establishment of site recycling committees charged with the responsibility of developing and implementing comprehensive and solid waste management programs designed to achieve the objectives of this policy.

 

11.                ALTERNATIVES TO THE PROPOSED ACTION

 

The environmental impact of manufacturing WELLBUTRIN (bupropion hydrochloride) tablets is expected to be minimal based on the low toxicity of bupropion hydrochloride in mammalian and microbial systems, and the low emissions to the environment, where non-persistence was demonstrated in the targeted aquatic compartment.  The only alternative to avoid any potential adverse environmental impact is to eliminate the production of this product.  However, there would be a cost involved in taking this “no action”, namely that Burroughs Wellcome Co. would not be provided an efficacious and safe drug to patients.  Though there are other antidepressants drugs available, WELLBUTRIN (bupropion hydrochloride) has been shown to be well tolerated and effective in treating depression.

 

 

 

 

 

 

 

Back a Page
Next Page
Back to Wellbutrin SR® NDA Index Page
Back to Main Index